{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:19:50Z","timestamp":1781612390664,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-050"],"award-info":[{"award-number":["2021-I2M-1-050"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.nutres.2025.12.010","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T07:18:53Z","timestamp":1766992733000},"page":"97-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Elevated C18:1-acylcarnitine is associated with a higher fibrosis-4 index through inflammation mediation: A cross-sectional study"],"prefix":"10.1016","volume":"146","author":[{"given":"Han","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2567-1439","authenticated-orcid":false,"given":"Qi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nutres.2025.12.010_bib0001","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.nutres.2025.12.010_bib0002","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.nutres.2025.12.010_bib0003","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.32163","article-title":"Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases","volume":"75","author":"Gines","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.nutres.2025.12.010_bib0005","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.nutres.2025.12.010_bib0006","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.nutres.2025.12.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/JCI189953","article-title":"Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD","volume":"135","author":"Munk Lauridsen","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nutres.2025.12.010_bib0008","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jgg.2019.11.009","article-title":"Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression","volume":"47","author":"Wang","year":"2020","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.nutres.2025.12.010_bib0009","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.nutres.2025.12.010_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrm3522","article-title":"Amino acid signalling upstream of mTOR","volume":"14","author":"Jewell","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0011","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s42255-019-0059-2","article-title":"Branched chain amino acids impact health and lifespan indirectly via amino acid balance and appetite control","volume":"1","author":"Solon-Biet","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.nutres.2025.12.010_bib0012","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1136\/gutjnl-2018-317584","article-title":"Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease","volume":"68","author":"Caussy","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.nutres.2025.12.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154005","article-title":"Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study","volume":"101","author":"Perakakis","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.nutres.2025.12.010_bib0014","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","article-title":"Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options","volume":"119","author":"Grander","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nutres.2025.12.010_bib0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0016","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0017","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.2337\/dc25-S004","article-title":"Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nutres.2025.12.010_bib0018","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nutres.2025.12.010_bib0019","first-page":"748","article-title":"Expert recommendations on standardized diagnosis and treatment for fatty liver disease in China (2019 revised edition)","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.nutres.2025.12.010_bib0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.nutres.2025.12.010_bib0021","first-page":"1915","article-title":"Expression of GLS1 in intrahepatic cholangiocarcinoma and its clinical significance","volume":"20","author":"Cao","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.nutres.2025.12.010_bib0022","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nutres.2025.12.010_bib0023","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.apsb.2022.03.014","article-title":"Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1alpha\/NF-kappaB feedback pathway to inhibit liver fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nutres.2025.12.010_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137037","article-title":"Origin and roles of alanine and glutamine in gluconeogenesis in the liver, kidneys, and small intestine under physiological and pathological conditions","volume":"25","author":"Holecek","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nutres.2025.12.010_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s42255-021-00369-9","article-title":"Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes","volume":"3","author":"Okun","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.nutres.2025.12.010_bib0026","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","article-title":"Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials","volume":"74","author":"Dambrova","year":"2022","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nutres.2025.12.010_bib0027","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep.24140","article-title":"Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation","volume":"53","author":"Orellana-Gavalda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.nutres.2025.12.010_bib0028","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12876-020-01190-6","article-title":"Blood carnitine profiling on tandem mass spectrometry in liver cirrhotic patients","volume":"20","author":"Miyaaki","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0029","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4254\/wjh.v14.i1.168","article-title":"Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence","volume":"14","author":"Jeyakumar","year":"2022","journal-title":"World J Hepatol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0030","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1194\/jlr.M200189-JLR200","article-title":"Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia","volume":"43","author":"Attie","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.nutres.2025.12.010_bib0031","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines\u2013old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0032","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174604","article-title":"Preventive and therapeutic role of betaine in liver disease: a review on molecular mechanisms","volume":"912","author":"Wang","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1409972","article-title":"Betaine for the prevention and treatment of insulin resistance and fatty liver in a high-fat dietary model of insulin resistance in C57BL mice","volume":"11","author":"Kathirvel","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.nutres.2025.12.010_bib0035","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.biopha.2018.04.154","article-title":"Betaine protects mice against acetaminophen hepatotoxicity possibly via mitochondrial complex II and glutathione availability","volume":"103","author":"Khodayar","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nutres.2025.12.010_bib0036","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10020-024-00895-8","article-title":"Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis","volume":"30","author":"Jang","year":"2024","journal-title":"Mol Med"},{"key":"10.1016\/j.nutres.2025.12.010_bib0037","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/HEP.0000000000000985","article-title":"Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1alpha","volume":"82","author":"Hai","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.nutres.2025.12.010_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119943","article-title":"The glycine betaine role in neurodegenerative, cardiovascular, hepatic, and renal diseases: insights into disease and dysfunction networks","volume":"285","author":"Rosas-Rodriguez","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.nutres.2025.12.010_bib0039","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/fft2.70122","article-title":"Medicine-food plant polysaccharides modulate diabetes and diabetic complications through maintaining gut function: a review","volume":"6","author":"Long","year":"2025","journal-title":"Food Frontiers"},{"key":"10.1016\/j.nutres.2025.12.010_bib0040","article-title":"Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.nutres.2025.12.010_bib0041","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40265-020-01458-x","article-title":"Strategies targeting the innate immune response for the treatment of hepatitis C virus-associated liver fibrosis","volume":"81","author":"Sepulveda-Crespo","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.nutres.2025.12.010_bib0042","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.nutres.2025.12.010_bib0043","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/DMSO.S330526","article-title":"Diagnostic value of neutrophil to lymphocyte ratio in non-alcoholic fatty liver disease evaluated using transient elastography (TE) with controlled attenuated parameter (CAP)","volume":"15","author":"Lesmana","year":"2022","journal-title":"Diabetes Metab Syndr Obes"}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531725001605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531725001605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:25:19Z","timestamp":1770794719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531725001605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"alternative-id":["S0271531725001605"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2025.12.010","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated C18:1-acylcarnitine is associated with a higher fibrosis-4 index through inflammation mediation: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Nutrition Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nutres.2025.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}